SEC Form D private-offering filing

Triana Biomedicines, Inc.

Name: Triana Biomedicines, Inc. - new SEC Form D private-offering filing, Lexington, MA
Published: 2025-12-04

A new SEC Form D private-offering notice from Lexington, MA, a $120,061,960 filer-stated offering target in Biotech. The source filing is one click away.

Triana Biomedicines, Inc. site↗ Verified via SEC Form D

Biotechnology company developing molecular glue degrader therapeutics targeting cancer, including an ALK-targeted lead program.

Filed 2025-12-04Filed to raise $120,061,960First money in 2025-11-26Raised so far $120,061,960HQ (as filed) Lexington, MASector Biotech ✓Stage (inferred) LateCall status Call-ready

Source linked the Form D on EDGAR↗Website verified trianabio.com↗Named in the filing 8 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.